Personalized Neoantigen-pulsed Autologous Dendritic Cell Injections for Malignant Solid Tumors

NCT07752953 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor
Cancer
Malignant Solid Tumor

Interventions

BIOLOGICAL: Personalized neoantigen-pulsed autologous dendritic cell Injections （ZSNeo-DC）
DRUG: Immune Checkpoint Inhibitors

Sponsor

ZSky Biotech Inc